SCHEMBL1664628

SCHEMBL1664628

Cc1cc(C(=O)Nc2ccc(Nc3ccc(Nc4ccc(N5CCC(O)CC5)cc4)cc3)c(F)c2)c[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.42
TP53 P04637 3/20 0.42
MAPT P10636 7/20 0.41
LMNA P02545 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
CSF1R P07333 1/20 0.41
NPC1 O15118 6/20 0.41
RAB9A P51151 6/20 0.41
SMN1; SMN2 Q16637 6/20 0.41
HTT P42858 2/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
PDE7A Q13946 3/20 0.41
HDAC3 O15379 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
GAA P10253 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1665841 0.96 RAB9A (0.47) SLC2A1TP53MAPTLMNATDP1
SCHEMBL1664630 0.96 RAB9A (0.47) SLC2A1TP53MAPTLMNATDP1
SCHEMBL1665248 0.89 NPC1 (0.51) TP53MAPTLMNANPC1RAB9A
SCHEMBL1665250 0.87 RAB9A (0.53) TP53MAPTLMNANPC1RAB9A
SCHEMBL1664879 0.86 NPC1 (0.41) SLC2A1TP53MAPTLMNANPC1
SCHEMBL1664659 0.86 SETD2 (0.40) SLC2A1MAPTLMNATDP1CSF1R
SCHEMBL1666529 0.86 MAPT (0.41) SLC2A1TP53MAPTTDP1CSF1R
SCHEMBL1664661 0.85 SLC2A1 (0.44) SLC2A1TP53MAPTLMNATDP1
SCHEMBL6125945 0.85 PDE7A (0.40) SLC2A1MAPTCSF1RALDH1A1PDE7A
SCHEMBL6120725 0.85 RAB9A (0.51) SLC2A1TP53MAPTLMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed